Trial Profile
RADIOCHEMIOTERAPIA CON TEMOZOLOMIDE CONCOMITANTE E ADIUVANTE NEL TRATTAMENTO DEI LINFOMI CEREBRALI PRIMITIVI DOPO METOTREXATE AD ALTE DOSI: STUDIO DI DOSE ESCALATION [RADIOCHEMIOTHERAPY WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE IN THE TREATMENT OF PRIMITIVE CEREBRAL LYMPHOMES AFTER HIGH-DOSE METHOTREXATE: STUDY OF DOSE ESCALATION.]
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Oct 2020
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications CNS cancer
- Focus Adverse reactions
- 01 Oct 2020 Results published in the Annals of Hematology
- 01 Oct 2020 Status changed from recruiting to completed as per results published in the Annals of Hematology.
- 01 Sep 2011 New trial record